Reynald Thinard

Mr. Reynald Thinard

ALSaTECH, Inc., Boston, Massachusetts, USA

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2016 in Cell Reports
Verified
Journal Article
Open access
JRJean-Baptiste Renaud
Jean-Baptiste Renaud
CBCharlotte Boix
Charlotte Boix
MCMarine Charpentier
Marine Charpentier
ACAnne De Cian
Anne De Cian
JCJulien Cochennec
Julien Cochennec
CGCarine Giovannangeli
Carine Giovannangeli
Genome editing has now been reported in many systems using TALEN and CRISPR-Cas9 nucleases. Precise mutations can be introduced during homology-directed repair with donor DNA carrying the wanted sequence edit, but efficiency is usually lower than for gene knockout and optimal strategies have not been extensively investigated. Here, we show that using phosphorothioate-modified oligonucleotides strongly enhances genome editing efficiency of single-stranded oligonucleotide donors in cultured cells. In addition, it provides better design flexibility, allowing insertions more than 100 bp long. Despite previous reports of phosphorothioate-modified oligonucleotide toxicity, clones of edited cells are readily isolated and targeted sequence insertions are achieved in rats and mice with very high frequency, allowing for homozygous loxP site insertion at the mouse ROSA locus in particular. Finally, when detected, imprecise knockin events exhibit indels that are asymmetrically positioned, consistent with genome editing taking place by two steps of single-strand annealing.

7 October 2015 in Scientific Reports
Verified
Journal Article
Open access
PDF file
SMSéverine Ménoret
Séverine Ménoret
ACAnne De Cian
Anne De Cian
LTLaurent Tesson
Laurent Tesson
SRSéverine Remy
Séverine Remy
CUClaire Usal
Claire Usal
IAIgnacio Anegon
Ignacio Anegon
The generation of genetically-modified organisms has been revolutionized by the development of new genome editing technologies based on the use of gene-specific nucleases, such as meganucleases, ZFNs, TALENs and CRISPRs-Cas9 systems. The most rapid and cost-effective way to generate genetically-modified animals is by microinjection of the nucleic acids encoding gene-specific nucleases into zygotes. However, the efficiency of the procedure can still be improved. In this work we aim to increase the efficiency of CRISPRs-Cas9 and TALENs homology-directed repair by using TALENs and Cas9 proteins, instead of mRNA, microinjected into rat and mouse zygotes along with long or short donor DNAs. We observed that Cas9 protein was more efficient at homology-directed repair than mRNA, while TALEN protein was less efficient than mRNA at inducing homology-directed repair. Our results indicate that the use of Cas9 protein could represent a simple and practical methodological alternative to Cas9 mRNA in the generation of genetically-modified rats and mice as well as probably some other mammals.

12 November 2012 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
SMSéverine Ménoret
Séverine Ménoret
SFSandra Fontanière
Sandra Fontanière
DJDerek Jantz
Derek Jantz
LTLaurent Tesson
Laurent Tesson
RTReynald Thinard
Reynald Thinard
IAIgnacio Anegon
Ignacio Anegon
Despite the recent availability of gene‐specific nucleases, such as zinc‐finger nucleases (ZFNs) and transcription activator‐like nucleases (TALENs), there is still a need for new tools to modify the genome of different species in an efficient, rapid, and less costly manner. One aim of this study was to apply, for the first time, engineered meganucleases to mutate an endogenous gene in animal zygotes. The second aim was to target the mouse and rat recombination activating gene 1 ( Rag1 ) to describe, for the first time, Rag1 knockout immunodeficient rats. We microinjected a plasmid encoding a meganuclease for Rag1 into the pronucleus of mouse and rat zygotes. Mutant animals were detected by PCR sequencing of the targeted sequence. A homozygous RAG1‐deficient rat line was generated and immunophenotyped. Meganucleases were efficient, because 3.4 and 0.6% of mouse and rat microinjected zygotes, respectively, generated mutated animals. RAG1‐deficient rats showed significantly decreased proportions and numbers of immature and mature T and B lymphocytes and normal NK cells vs. littermate wild‐type controls. In summary, we describe the use of engineered meganucleases to inactivate an endogenous gene with efficiencies comparable to those of ZFNs and TALENs. Moreover, we generated an immunodeficient rat line useful for studies in which there is a need for biological parameters to be analyzed in the absence of immune responses.—Ménoret, S., Fontanière, S., Jantz, D., Tesson, L., Thinard, R., Rémy, S., Usal, C., Ouisse, L.‐H., Fraichard, A., Anegon, A. Generation of Rag1 ‐knockout immunodeficient rats and mice using engineered meganucleases. FASEB J. 27, 703–711 (2013). www.fasebj.org

1 March 2011 in Behavioural Brain Research
Verified
Journal Article
Closed access
Julien RossignolJulien Rossignol
Julien Rossignol
CBCécile Boyer
Cécile Boyer
XLXavier Lévèque
Xavier Lévèque
KFKyle D. Fink
Kyle D. Fink
RTReynald Thinard
Reynald Thinard
LLLaurent Lescaudron
Laurent Lescaudron

2 July 2014 in Genome Research
Verified
Journal Article
Open access
PDF file
SRSéverine Remy
Séverine Remy
LTLaurent Tesson
Laurent Tesson
SMSéverine Menoret
Séverine Menoret
CUClaire Usal
Claire Usal
ACAnne De Cian
Anne De Cian
IAIgnacio Anegon
Ignacio Anegon
The generation of genetically modified animals is important for both research and commercial purposes. The rat is an important model organism that until recently lacked efficient genetic engineering tools. Sequence-specific nucleases, such as ZFNs, TALE nucleases, and CRISPR/Cas9 have allowed the creation of rat knockout models. Genetic engineering by homology-directed repair (HDR) is utilized to create animals expressing transgenes in a controlled way and to introduce precise genetic modifications. We applied TALE nucleases and donor DNA microinjection into zygotes to generate HDR-modified rats with large new sequences introduced into three different loci with high efficiency (0.62%–5.13% of microinjected zygotes). Two of these loci (Rosa26 and Hprt1) are known to allow robust and reproducible transgene expression and were targeted for integration of a GFP expression cassette driven by the CAG promoter. GFP-expressing embryos and four Rosa26 GFP rat lines analyzed showed strong and widespread GFP expression in most cells of all analyzed tissues. The third targeted locus was Ighm, where we performed successful exon exchange of rat exon 2 for the human one. At all three loci we observed HDR only when using linear and not circular donor DNA. Mild hypothermic (30°C) culture of zygotes after microinjection increased HDR efficiency for some loci. Our study demonstrates that TALE nuclease and donor DNA microinjection into rat zygotes results in efficient and reproducible targeted donor integration by HDR. This allowed creation of genetically modified rats in a work-, cost-, and time-effective manner.

1 January 2011 in Parkinson's Disease
Verified
Journal Article
Open access
PDF file
FLFaustine Lelan
Faustine Lelan
CBCécile Boyer
Cécile Boyer
RTReynald Thinard
Reynald Thinard
SRSéverine Rémy
Séverine Rémy
CUClaire Usal
Claire Usal
LLLaurent Lescaudron
Laurent Lescaudron
A transgenic Sprague Dawley rat bearing the A30P and A53Tα-synuclein (α-syn) human mutations under the control of the tyrosine hydroxylase promoter was generated in order to get a better understanding of the role of the humanα-syn mutations on the neuropathological events involved in the progression of the Parkinson’s disease (PD). This rat displayed olfactory deficits in the absence of motor impairments as observed in most early PD cases. In order to investigate the role of the mutatedα-syn on cell proliferation, we focused on the subventricular zone (SVZ) and the olfactory bulbs (OB) as a change of the proliferation could affect OB function. The effect on OB dopaminergic innervation was investigated. The humanα-syn co-localized in TH-positive OB neurons. No humanα-syn was visualized in the SVZ. A significant increase in resident cell proliferation in the glomerular but not in the granular layers of the OB and in the SVZ was observed. TH innervation was significantly increased within the glomerular layer without an increase in the size of the glomeruli. Our rat could be a good model to investigate the role of human mutatedα-syn on the development of olfactory deficits.